Total pelvic exenteration for primary locally advanced and recurrent rectal cancer
Maarten Vermaas(Association of British Orchestras), J. De Wilt, Floris Ferenschild(Erasmus MC Cancer Institute), Theo Wiggers(University Medical Center Groningen), Cornelis Verhoef(Erasmus MC Cancer Institute), Andreas Marinelli(Medisch Centrum Haaglanden), Joost J. Nuyttens(Erasmus MC Cancer Institute), A.M.M. Eggermont(Praxis für Hämatologie und Onkologie)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
|British journal of surgery|2004|665
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
Body composition and outcome in patients undergoing resection of colorectal liver metastases19
|British journal of surgery|2012|464